MannKind | MNKD - Lieferungen Und Leistungen





Lieferungen Und Leistungen Veränderung Datum
Adma Biologics USD 20.52M 2M 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
Insmed USD 73.38M 6.53M 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
MacroGenics USD 4.29M 500K 2026-03
MannKind USD 16.14M 7.11M 2026-03
Merck USD 3.86B 541M 2026-03
Minerva Neurosciences USD 640K 305K 2025-12
Novavax USD 16.1M 8.48M 2026-03
Novo Nordisk DKK 4.46B 15.12B 2025-06
Pfizer USD 4.51B 734M 2026-03
Sanofi EUR 22.71B 219M 2026-03
Xencor USD 7.92M 2.91M 2026-03